Optimal Treatment of cT1b Renal Mass in Patient with Normal GFR: a Role for Radical Nephrectomy?

Steven C. Campbell, MD, PhD of The Cleveland Clinic discusses “Optimal Treatment of cT1b Renal Mass in Patient with Normal GFR: a Role for Radical Nephrectomy?” at the 14th International Kidney Cancer Symposium.

Advertisement Single Below Content

Optimal Treatment of cT1b Renal Mass in Patient with Normal GFR: a Role for Radical Nephrectomy?

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Optimal Treatment of cT1b Renal Mass in Patient with Normal GFR: a Role for Radical Nephrectomy?

Related Posts

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia